Blood Safety
Canada Blood Scandal Inquiry Calls for Compensation
Published in Blood Weekly, December 8th, 1997
The inquiry was called more than four years ago after some 1,200 Canadians were infected with HIV and another 12,000-27,000 were infected with hepatitis C in the 1980s and early 1990s because of improperly-screened blood.
"It is recommended that, without delay, the provinces and territories devise statutory no-fault schemes for compensating persons who suffer serious, adverse consequences as a result of the administration of blood components or blood products," Justice Horace Krever wrote in his...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (1997-12-08)
More Articles from Blood Weekly
- Tissue Banking (Creutzfeldt-Jakob Disease)
CJD-Contaminated Grafts May Place Recipients at Risk for Up to 16 Years - Blood Banking
Leukodepletion Recommended to Reduce Risk of New Variant CJD in U.K. - Blood Banking (Chagas' disease)
Testing Only Donors at Risk for T. cruzi Infection May Be Ineffective - Blood Banking (Cryopreservation)
Frozen Red Cells Show Acceptable Survival with Addition of Dextran - Chronic Myeloid Leukemia (Conference News)
IFN-(alpha) Transfected Marrow Cells Have Antiproliferative Effect - Epidemiology (Chagas' Disease)
Rural Immigrants Affect T. cruzi Prevalence in Belize - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
